CanSino to start Phase III trial of COVID-19 vaccine in Saudi Arabia
Submitted by mike kraft on
DUBAI (Reuters) - Saudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics Inc, a Saudi health ministry spokesman said on Sunday.